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Longitudinal Strain Delay Index by Speckle
Tracking Imaging
A New Marker of Response to Cardiac Resynchronization Therapy
Pascal Lim, MD; Adisai Buakhamsri, MD; Zoran B. Popovic, MD, PhD; Neil L. Greenberg, PhD;
Dimpi Patel, MD; James D. Thomas, MD; Richard A. Grimm, DO
Background—In heart failure patients with left ventricular dyssynchrony, contractility in delayed segments does not fully
contribute to end-systolic function. We quantified this reserve of contraction related to mechanical dyssynchrony to
predict response to cardiac resynchronization therapy by the strain delay index, which was defined as the sum of the
difference between peak and end-systolic strain across 16 segments.
Methods and Results—In 100 heart failure patients (ejection fraction269%, QRS15429 ms, 94% in New York
Heart Association class III), we studied left ventricular dyssynchrony before cardiac resynchronization therapy by the
strain delay index using longitudinal strain by 2D speckle tracking and by the SD of time to peak myocardial velocity
in 12 segments. The optimal cutoff value of the strain delay index to predict response to cardiac resynchronization
therapy was determined in a retrospective group (n65) and then confirmed in a validation group (n35). Left
ventricular end-systolic volume reduction at 3 months 15% (responder) occurred in 64 of 100 patients. In the
retrospective group, the strain delay index but not the SD of time to peak myocardial velocity was greater in responders
(n42/65) than nonresponders (358% versus 197%, P0.0001), and the optimal cutoff value to identify response
to cardiac resynchronization therapy was 25%. In the validation group, strain delay index 25% identified 82% (18/22)
of responders and 92% (12/13) of nonresponders. Among the entire population (n100), strain delay index correlated
with reverse remodeling in both the ischemic (r0.68, P0.0001) and nonischemic (r0.68, P0.0001)
population.
Conclusions—Use of the strain delay index with longitudinal strain by speckle tracking has a strong predictive value for
predicting response to cardiac resynchronization therapy in both ischemic and nonischemic patients. (Circulation. 2008;
118:1130-1137.)
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Several large clinical trials have established the long-termbenefits (such as improvement of symptoms,1–8 ejection
fraction,2,4,8 mitral regurgitation,1,4 left ventricular [LV] re-
modeling,1,2,4 and survival8) with cardiac resynchronization
therapy (CRT) in symptomatic patients who have severe LV
dysfunction and a wide QRS complex.1–8 Despite these
promising results, 30% of patients selected on the basis of
QRS duration do not respond to CRT.8 Observational studies
have consistently shown that the main predictor of respon-
siveness to CRT is mechanical rather than electrical dyssyn-
chrony.9 Measurement of regional myocardial electrical-
mechanical events with velocity data acquired with tissue
Doppler imaging (TDI)10,11 has been shown to enhance
identification of mechanical dyssynchrony and can be used to
select patients who may better respond to CRT; however,
limitations of this technique still exist, in particular the lack of
specificity associated with delayed contraction in patients
with ischemic cardiomyopathy.12,13 Patients with significant
mechanical dyssynchrony may be nonresponsive because
myocardial segments may be scarred and therefore lack
residual contractility. This phenomenon is particularly evi-
dent in ischemic patients who have myocardial segments with
delayed contraction, which is often caused by scar.14–16
Current identification of responders by time-delay indexes
alone is inherently limited, because residual myocardial
contraction is not taken into account. To overcome these
limitations, we propose a new method, the strain delay index.
The strain delay index can predict response to CRT by
directly assessing the potential for incremental contractility
gain after resynchronization rather than by simply quantify-
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ing LV dyssynchrony by regional timing. In the present
study, the strain delay index was calculated by use of
longitudinal strain () assessed by 2D speckle tracking, which
was then compared to the SD of time to peak velocity and
time to peak longitudinal strain to predict future reverse
remodeling after CRT.
Clinical Perspective p 1137
Methods
Population
The study included 100 patients with symptomatic heart failure (HF),
an ejection fraction 35%, and QRS duration 120 ms who had
conventional TDI and longitudinal  analysis by 2D speckle tracking
before undergoing implantation of a biventricular device. The study
was conducted in 2 consecutive groups of patients, with hypothesis
testing to determine the optimal cutoff value for the strain delay
index to predict response to CRT, which was first assessed in a
retrospective cohort (derivation group, n65) followed by validation
in a prospective cohort (validation group, n35).
Derivation Group
The derivation group was selected from 589 consecutive HF patients
who underwent implantation of a biventricular device at the Cleve-
land Clinic (Cleveland, Ohio) between January 2005 and December
2006. Patients were selected if they had a complete baseline
echocardiographic study performed 3 months before device implan-
tation on a Vivid 7 system (GE, Vingmed System 7, Horten,
Norway) and if an echocardiographic follow up (3 months) was
available (120 of 589 patients). Complete baseline echocardiography
included standard gray-scale and color TDI in the apical views (2-,
3-, and 4-chamber views) with high frame rates (35 frames/s). Of
these 120 selected patients 50 were excluded (5 with implantation
3 months after an acute coronary syndrome or cardiac surgery, 41
with2 nonanalyzable segments by 2D speckle tracking or TDI, and
4 with permanent atrial fibrillation). After device implantation,
another 5 patients were excluded (inadequate CRT delivery, ie, LV
pacing rate was 50%; 3 with paroxysmal atrial fibrillation and 2
owing to an increased LV lead threshold). Ultimately, 65 patients
were entered into the derivation group.
Validation Group
This phase of the study was conducted prospectively in a cohort of
HF patients recruited consecutively before biventricular device
implantation at Cleveland Clinic from January 2007 to May 2007.
Patients were included if they met all of the following criteria:
symptomatic HF, age between 18 and 75 years, LV ejection fraction
35%, and sinus rhythm with QRS duration 120 ms. Exclusion
criteria were recent cardiac event (3 months after an acute coronary
syndrome or cardiac surgery), inadequate CRT delivery after
3-month follow-up (LV pacing rate 50%), and 2 nonanalyzable
segments by either speckle tracking or TDI. Patients in the study
(n40) underwent 2D echocardiographs before device implantation
on a Vivid 7 system with a high frame rate and color TDI in the
apical views. At 3 months, 2D echocardiography was repeated to
quantify reverse remodeling after CRT. Five patients were excluded
because of limited echocardiographic images and inadequate CRT
delivery during the 3-month follow up. Overall, 35 patients were
selected as the validation group. All patients had given informed
consent, and the study protocol was approved by the Cleveland
Clinic Institutional Review Board.
Biventricular Pacemaker Implantation
CRT was provided in the standard fashion with 3 transvenous leads
inserted. The right atrial and ventricular (apical site) leads were
positioned conventionally. The LV lead was inserted through the
coronary sinus and positioned into the lateral (n38), posterolateral
(n43), anterolateral (n8), or middle (n4) cardiac vein. Epicar-
dial implantation was required in 7 patients. Biventricular pacing
devices used included those manufactured by Medtronic (Minneap-
olis, Minn; n59), St Jude Medical (Sylmar, Calif; n27), and
Guidant–Johnson & Johnson (Boston, Mass; n14). After implan-
tation, the atrioventricular interval was adjusted for optimal diastolic
filling by Doppler echocardiographic assessment of mitral inflow,
and V-V timing was programmed to be simultaneous in all cases. All
devices were interrogated systematically within 3 months after the
CRT procedure to ascertain their proper functioning.
Follow-Up
Baseline and 3-month clinical characteristics were extracted from
medical reports. Responders were defined by the presence of significant
reverse remodeling (LV end-systolic volume [ESV] reduction15% by
Simpson biplane method) at 3 months after CRT.
Strain Delay Index
In dyssynchronous ventricles, delayed segments do not contribute
fully to end-systolic (ES) function. The wasted energy per segment
caused by dyssynchrony can be expressed mathematically as the
difference between peak (peak) and ES strain (ES). Theoretically, this
difference (ESpeak) increases with the severity of dyssynchrony
(Figures 1 and 2A). The wasted energy is expected to be greater in
the segment with preserved contractility than in the segment with no
or minimal residual contractility at a similar degree of delayed
contraction. This can be well appreciated in scar or fibrotic myocar-
dium (Figure 2B). The strain delay index (Figure 3) represents the
sum of the wasted energy due to LV dyssynchrony across all (n)
myocardial segments:
strain delay index
1
n
(peakES)
The strain delay index can be computed from any quantitative
regional wall-motion method, because it expresses a difference of
contractility amplitude; however, its accuracy depends on the preci-
sion of the method for quantifying regional wall motion. Prior to this
investigation, we compared longitudinal, transversal, circumferen-
tial, and radial  by 2D speckle tracking, TDI-derived myocardial
velocity, and TDI-derived longitudinal  in 29 HF patients (Supple-
mental Table I). We observed that regional peak longitudinal  by
speckle tracking provided an accurate measure of regional myocar-
dial wall motion, with global peak strain closely correlated to LV
ejection fraction (r0.84, P0.0001; Supplemental Table II). The
strain delay index was then computed from longitudinal  by 2D
εpeak
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Longitudinal ε
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) εpeak
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Longitudinal ε
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A B
Figure 1. In dyssynchronized myocardium, -peak
of delayed segment does not fully contribute to ES
function. The wasted energy due to dyssynchrony
is mathematically expressed as the difference
(peakES) in postsystolic (A) and presystolic (B)
segments. AVC indicates aortic valve closure.
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speckle tracking (EchoPac version 7.0.0, GE Vingmed). The peak of
the R wave on the ECG was used as the reference time point for end
diastole. Strain curves derived from a single cardiac cycle were
exported for an automatic analysis in Excel. The different steps of
strain delay index processing can be summarized as follows: First,
we computed a global  curve representing LV function by averaging
16 regional LV  curves. To average strain curves with different RR
intervals and frame rates, we normalized the time as a percent of the
RR interval, and strain value at every 2.5% of the RR interval was
calculated with linear interpolation for missing values. Second, we
used the time to the peak of this global  curve to determine the
timing of ES and to compute the ES in the 16 segments. Third, we
also defined peak and time to peak  in the 16 segments as the 
curve reached its minimum value during the cardiac cycle. Finally,
the difference (peakES) in each segment (all 16 segments) was
summed to generate the strain delay index. For a segment that
exhibited positive strain or biphasic strain with a peak positive 
greater than the maximal absolute negative strain, the term
AVCAVC
   Timing     Scar-Fibrosis
Longitudinal ε
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εES
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εpeak
εpeak
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Figure 2. Effects of time to peak strain and status
of myocardium on wasted contractile energy. The-
oretically, the wasted energy due to dyssynchrony
(peakES) in each segment increases with the
severity of the delayed contraction (A). For seg-
ments with a similar degree of dyssynchrony (B),
the difference (peakES) would be greater in a
myocardial segment with preserved contractility
than in those with no or minimal residual contrac-
tility, as in scar or fibrotic myocardial tissue. AVC
indicates aortic valve closure.
Figure 3. A, Strain delay index is defined as the sum of the wasted energy, ie, (ESpeak) caused by LV dyssynchrony across the 16
myocardial segments (colored curves) of the LV. B, After CRT, the increase () of global strain curve (white dashed curve) is supposed
to be proportional to strain delay index.
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(peakES) was entered as zero for the calculation of strain delay
index. This methodology is based on the assumption that dyskinetic
segments with predominant stretch are unlikely to be improved
immediately by CRT. Time to peak longitudinal  by speckle
tracking was used to calculate the 12-segment (base and mid) SD of
time to peak- (SD). In segments with positive or biphasic strain
curve, time to absolute maximal  was chosen to compute SD-.
TDI Analysis
We also defined LV dyssynchrony using the SD in 12 segments of
time to peak velocity by TDI (SD-TDI) and the septal-lateral delay
of time to peak velocity (TSL). These indexes were computed
automatically with modified software developed in our laboratory.
Automatic and manual measurements were compared in 20 random
patients and results reported with Bland-Altman analysis (Data
Supplement, Figure I). The process can be summarized as follows:
(1) Basal and midventricular velocity curves (n12) derived from
color TDI sequences (EchoPac version 7.0.0) were exported for
analysis in Excel. (2) Time to peak velocity was defined when peak
velocity reached its maximum positive value during the systolic ejection
period. (3) The reference timing point was defined at end diastole (at the
peak of the R wave on the ECG tracing), and the systolic period was
defined by aortic valve opening and closure with LV outflow tract
pulse-wave Doppler flow. (4) Segments with only negative velocity
during the systolic ejection period were excluded from the calculation of
SD-TDI and TSL. Significant LV dyssynchrony was considered when
SD-TDI was 33 ms10 and TSL was 65 ms.11
Statistical Analysis
Continuous variables with normal distribution are expressed as
meanSD. Dichotomous data are expressed as percentages. To
compare numerical data between 2 groups, paired and unpaired
Student tests were used when appropriate. Dichotomized compari-
sons were assessed by 2 test or the Fisher exact test. Receiver
operating characteristic curves were determined to evaluate the
diagnostic performance of LV dyssynchrony indexes to detect respond-
ers to CRT. An optimal cutoff value for the diagnosis of responders was
chosen to maximize the Youden index (sensitivityspecificity1). The
optimal cutoff value of strain delay index was assessed in the derivation
group, and then the accuracy was confirmed in the validation group.
Linear correlation was used to compare LV ESV reduction and
strain delay index. Reproducibility was performed in 10 randomly
selected patients. Interobserver and intraobserver variability were
expressed as the SD of the difference between 2 paired measure-
ments and as a percentage of variability (SD was divided by the
average value of the variable). Two-tailed probability values 0.05
were considered statistically significant.
The authors had full access to the data and take full responsibility for
its integrity. All authors have read and agree to the manuscript as
written.
Results
The entire study population averaged 6312 years of age;
94% were in New York Heart Association class III, with
ejection fraction of 269% (35% with ischemic origin of HF)
and QRS duration of 15429 ms. Baseline characteristics of
the derivation and validation populations are summarized in
Supplemental Table III. After 3 months of CRT, 53 of 100
patients were clinically improved by CRT, 35 (54%) of 65 in
the derivation group and 18 (51%) of 35 in the validation
group. Eleven patients experienced worsening symptoms, 7
(11%) in the derivation group (4 died and 2 underwent heart
transplantation) and 4 (11%) in the validation group (1 died).
The overall population had a mean LV ESV reduction of
17.624% (range 54% to 66%); 64 patients had ESV
reduction 15%, 14 had reductions between 0% and 15%,
and 22 had increased ESV. Baseline clinical and echocardio-
graphic parameters were similar between responders and
nonresponders in the 2 populations (Table 1).
Derivation Group
TDI and Strain for Reverse Remodeling
In the initial 65 patients, ESV reduction at 3 months was
1624% (range 54% to 59%). In 42 (65%) of 65 patients,
ESV reduction was 15%; in 6 (9%), it was between 0% and
15%; and in 17 (26%), the ESV increased. Neither SD-TDI
(5217 ms, range 19 to 93 ms) nor the opposing-wall TSL
(10051 ms, range 0 to 250 ms) correlated with QRS duration
or reverse remodeling (r0.2, P0.1 for SD-TDI; r0.2 P0.1
for TSL). Significant dyssynchrony by TDI (SD-TDI 33ms)
was observed in 59 (91%) of 65 patients and did not differ
between responders and nonresponders (37/42 versus 22/23,
P0.3; mean 5116 versus 5614 ms, P0.2). Similarly, TSL
65 ms was observed in 51 (78%) of 65 patients and did not
Table. Comparison Between Responders and Nonresponders
Retrospective Group (n65) Prospective Group (n35)
Responders,
n42 (64%)
Nonresponders,
n23 (36%)
Responders,
n22 (63%)
Nonresponders,
n13 (37%)
Age, y 6510 6313 6213 6212
Male sex, n (%) 33 (79) 18 (78) 12 (54) 7 (54)
Baseline NYHA class III, n (%) 39 (93) 23 (100) 21 (95) 11 (85)
QRS duration, ms 15728 14426 15626 15937
Baseline ejection fraction, % 2610 236 2710 279
End-diastolic volume, mL 22585 26087 20572 243122
ESV, mL 16975 20072 15263 187120
Ischemic, n (%) 14 (33) 11 (48) 5 (23) 5 (38)
Baseline medications, n (%)
-Blockers 36 (86) 20 (87) 18 (82) 11 (85)
ACEI/ARB 35 (83) 22 (95) 21 (95) 12 (92)
Spironolactone 17 (40) 14 (61) 10 (45) 6 (46)
ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.
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provide significant predictive value for CRT response. In con-
trast, SD- did correlate with baseline QRS duration (r0.42,
P0.001) and ESV reduction (r0.38, P0.002). Finally, the
correlation between reverse remodeling and SD- was signifi-
cant in nonischemic patients (r0.4, P0.01) but not in
ischemic patients (r0.35, P0.08).
Strain Delay Index for Reverse Remodeling
The strain delay index (2910%, range 6% to 52%) was
found to be higher in responders than nonresponders (357%
versus 196%, P0.0001). Furthermore, the strain delay
index increased with QRS duration (r0.32, P0.01) and
was closely correlated with reverse remodeling (r0.71 for
all, P0.0001; Figure 4) in both the ischemic (r0.68,
P0.001) and nonischemic (r0.71, P0.0001) patients.
All patients with a strain delay index 75th percentile
(35%) exhibited a significant LV ESV reduction (3313%,
range 15% to 57%), whereas all patients with a strain delay
index below the 25th percentile (20%) showed ESV reduc-
tion 10% (mean 1218%, range 54% to 10%). The
optimal cutoff value to predict response to CRT determined
from the receiver operating characteristic curve of the deri-
vation group was a strain delay index 25% (Figure 5). The
sensitivity, specificity, negative predictive value, and positive
predictive value were 95% (95% CI 87% to 99%), 83% (95%
CI 72% to 91%), 90% (95% CI 81% to 96%), and 90% (95%
CI 81% to 96%), respectively.
Validation Group
Validation of Strain Delay Index
The mean ESV reduction at 3 months was 2025% (range
40% to 70%). ESV reduction was 15% in 22 (63%) of 35
patients and between 0% and 15% in 8 (23%), and ESV
increased in 5 (14%). Strain delay index (289%, range 10 to
47%) was significantly greater in responders than nonre-
sponders (328% versus 205%, P0.0001). A strain delay
index cutoff 25% was observed in 18 of 22 patients (82%;
95% CI 66% to 93%) among responders and was25% in 12
(92%; 95% CI 77% to 98%) of 13 nonresponders. The
positive predictive value was 75% (95% CI 57% to 87%)
with a cutoff 25% and increased to 83% (95% CI 66% to
93%) with a strain delay index 20%. Conversely, the
negative predictive value was 95% (95% CI 81% to 99%)
with a cutoff 25% and decreased to 73% (95% CI 54% to
85%) with a strain delay index 20%. Similar to the
derivation group, the strain delay index correlated to reverse
remodeling after CRT (r0.68, P0.0001 for all) in the
ischemic (r0.68, P0.04) and nonischemic (r0.68,
P0.001) population. The correlation between strain delay
index and ESV reduction for the entire population (n100) is
displayed in Figure 6. In the validation group, SD- tended to
correlate with reverse remodeling (r0.37, P0.05),
whereas no significant association was observed for either
SD-TDI (r0.15, P0.5; Supplemental Figure II) or the
opposing-wall TSL (r0.1, P0.6).
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Figure 4. Correlation between strain delay index and ESV
reduction after CRT in ischemic and nonischemic patients in the
derivation group (n65).
Figure 5. Receiver operating characteristic curves for diagnosis
of response to CRT from the derivation group (n65). P value
for area under the curve (AUC) vs the null hypothesis of a true
area0.5.
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Figure 6. Correlation between strain delay index and ESV
reduction after CRT in ischemic and nonischemic patients
among the entire population of patients (n100).
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Reproducibility
Intraobserver and interobserver variability were, respectively,
20 mL (10%) and 25 mL (13%) for LV volume, 7 ms (13%)
and 9 ms (17%) for SD-TDI, 15 ms (17%) and 18 ms (21%)
for TSL, 19 ms (17%) and 27 ms (24%) for SD-, and 4%
(13%) and 6% (20%) for strain delay index.
Discussion
Reverse remodeling of the LV after CRT provides an objective
measurement for CRT response, which is correlated to improved
survival and LV function. In the present study, we defined CRT
response as ESV reduction 15%. This reduction was only
observed in 64% of patients despite the presence of a significant
prolonged QRS duration. LV mechanical dyssynchrony indexes
derived from time-delay measurements with TDI failed to
improve patient selection. In contrast, the strain delay index,
which quantifies the amount of wasted energy due to LV
dyssynchrony, was found to correlate closely with reverse
remodeling after CRT in both ischemic and nonischemic patient
populations (r0.69, P0.0001; Figure 6).
CRT has been shown to improve both the symptoms1–8 and
the prognosis8 of HF patients with depressed LV function and
a wide QRS complex; however, most CRT studies have
demonstrated that one third of patients are nonresponders,
presumably because mechanical dyssynchrony was absent
despite a wide QRS duration.8 Several methods based on the
time-delay measurement of regional wall motion have been
proposed to quantify LV dyssynchrony.9 Values for most of
these methods are obtainable with echocardiographic tech-
niques and are usually derived from longitudinal myocardial
velocity data by TDI.9 Several single-center studies have
demonstrated that a 12-segment SD-TDI 33 ms and an
opposing-wall delay TSL 65 ms correlated to the clinical
response to CRT.17 However, in a prospective, multicenter
setting in the Predictors of Response to CRT (PROSPECT)
study,18 which sought to test the performance of these
mechanical dyssynchrony markers, neither the SD-TDI nor
the opposing-wall delay was predictive of response to CRT.
In addition, the TDI parameters were highly variable, with an
interobserver variability 30%. In the present study, these
markers were also computed automatically with dedicated
software to improve reproducibility. Despite an objective
determination of time to peak velocity and a careful review of
velocity curves, neither an SD-TDI 33 ms nor an opposing-
wall TSL 65 ms correlated with response to CRT. The
limitations of time delay by TDI to assess LV dyssynchrony
to predict response to CRT in HF patients have also been
reported by others (Soliman et al19 and the REsynchroniza-
tion THerapy In Normal QRS [RETHINQ] trials20). The
suboptimal accuracy of TDI to predict response to CRT may
be explained by a drawback of the Doppler technique in HF
patients in which the signal-to-noise ratio of TDI is particu-
larly affected by myocardial dysfunction (minimal base to
apex motion), translational and tethering effects,21 and mal-
alignment of the Doppler sample volume, which increases as
LV geometry changes to a globular shape. These issues may
explain the difficulty in identifying peak contraction in the
flat velocity contour of the failing heart.22 This is particularly
salient in the present study, because the patients had signifi-
cantly larger LV volumes than those in the validation study
by Yu et al12 (23190 versus 19381 mL, P0.05).
Time delay from speckle tracking correlated with reverse
remodeling after CRT better than TDI and QRS duration. The
apparent superiority of the speckle tracking technique to
quantify intraventricular mechanical dyssynchrony is be-
lieved to be related to a lesser ultrasonic angle dependency of
the speckle tracking technique, as well as a better signal-to-
noise ratio of the strain signal than with TDI. Furthermore,
the predictive value of mechanical dyssynchrony for respon-
siveness to CRT also depends on the ability to detect viable
versus scarred myocardium, because this varies significantly
between ischemic and nonischemic or dilated cardiomyopa-
thies. Delayed contraction by TDI is a nonspecific marker for
myocardial dysfunction23,24 that can be seen in scar,14–16
fibrosis,25,26 and viable myocardium and may be further
impacted by loading conditions.14 Recently, several investi-
gators have suggested interrogating myocardial viability27–29
and contractile reserve30,31 as a complement to LV dyssyn-
chrony to better identify responders; however, this multimo-
dality approach can be costly and time-consuming, is possibly
oversimplified, and may not be practical in some centers.
In the present study, we proposed a new method to
overcome many of these limitations by applying a strain
amplitude technique from the baseline 2D echocardiographic
data rather than applying a time-delay–based measurement
alone. This concept to predict response to CRT is based on
the assessment of a component of wasted contractility related
to dyssynchrony that can be inferred as the acute gain of
contractility expected after resynchronization. The acute in-
crease in myocardial performance plays an important role in
the long-term effects of CRT, because it will help to reduce
LV wall stress and mitral regurgitation and trigger the
reverse-remodeling process. The degree of impaired contrac-
tility expressed by the strain delay index was not only derived
from delayed segments but also included presystolic seg-
ments. Time to peak strain in presystolic segments is also
expected to change under CRT with the improved synchro-
nicity of the LV32 to enable segments with early contraction
to more fully contribute to myocardial function.
Importantly, the strain delay index had similar accuracy in
patients with ischemic and nonischemic cardiomyopathies.
This may be explained by the robustness of the index, which
considers all 16 myocardial segments of the ventricle, and the
fact that the strain delay index is not a simple measurement of
contractility or time delay but a combination (and relative
weighting) of both of these parameters. Indeed, the delayed
myocardial segments incrementally impact the strain delay
index value not only in proportion to the severity of dyssyn-
chrony but also relative to the amplitude of their residual
contractility (Figure 2). Figure 7 demonstrates that the dif-
ference (peakES) is low (1%) in a segment with limited
dyssynchrony (5% delay from ES), as well as in a dyssyn-
chronized segment with severely impaired contractility (peak
less than 5%). This supports the concept that a scarred
segment with minimal contractility, which is less likely to
improve with CRT, will barely increase the strain delay index
primarily because of the small difference between peak and
ES despite the presence of significantly delayed contraction.
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Study Limitations
The results of the present study are limited to patients with wide
QRS duration and should not be extended to patients with QRS
120 ms until a specific validation study can be conducted in
this population. In addition, the quality of echocardiographic
images is important for all strain-based analysis; therefore, our
index may not reach its full capability if the image quality is
suboptimal. However, the strain delay index can be applied to
other imaging modalities. Next, LV ESV is critical for defining
responders to CRT. Other accurate measures, such as 3D
echocardiography, should be used in the future to reduce
observer-related variability. In the present study, the SD-TDI
was computed automatically with modified software rather than
manually as reported by Yu et al.10,17 We reported that SD-TDI
computed automatically was not accurate for identification of
responders to CRT, and according to recently published stud-
ies,18–21 this appears to be related to TDI limitations. However,
we cannot exclude the possibility that the automated approach
may be less accurate than the manual approach, which may be
effective in predicting response to CRT if performed in a
laboratory with special expert knowledge, skill, and experience.
Conclusions
The strain delay index from a longitudinal strain amplitude
measurement by 2D speckle tracking appears to be an accurate
predictor of CRT response both in ischemic and nonischemic
patients alike.
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CLINICAL PERSPECTIVE
Recent results from the PROSPECT and RETHINQ trials might suggest that a relatively limited and simple quantification of left
ventricular dyssynchrony has suboptimal accuracy for the identification of responders to cardiac resynchronization therapy. In the
present study, we introduce a new method, the strain delay index, to quantify response to cardiac resynchronization therapy. Rather than
simply measuring left ventricular dyssynchrony, we propose to quantify the potential gain of contractility expected after the best possible
cardiac resynchronization. The potential gain, in turn, should predict reverse remodeling after resynchronization therapy. The strain
delay index combines the importance of left ventricular dyssynchrony and residual contractility and provides a better understanding of
the physiological response to cardiac resynchronization therapy. This index should improve the ability to identify potential responders
to cardiac resynchronization therapy in the future. The sophistication of the strain delay index relative to Doppler-derived parameters
might be of particular importance in the narrow-QRS population, in whom the degree of dyssynchrony may be less and thus more
challenging to quantify. Future efforts should focus on validation of the method in current clinical practice along with implementation
of software modifications to facilitate ease of use. Additionally, because the strain delay index is computed from regional strain curves,
its accuracy is dependent on the precision of the method used to quantify myocardial contractility. Importantly, therefore, the strain delay
index can be computed from imaging modalities other than ultrasound (ie, cardiac magnetic resonance and CT) and should be tested
in patients with poor acoustic windows.
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